TM4SF20
Basic information
Region (hg38): 2:227362038-227381995
Links
Phenotypes
GenCC
Source:
- specific language impairment 5 (Limited), mode of inheritance: AD
- specific language impairment 5 (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Specific language impairment 5 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 23810381 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TM4SF20 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 24 | 33 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 1 | ||||
non coding | 4 | |||||
Total | 0 | 0 | 29 | 15 | 9 |
Variants in TM4SF20
This is a list of pathogenic ClinVar variants found in the TM4SF20 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-227363727-C-T | Likely benign (Oct 13, 2023) | |||
2-227363746-T-G | TM4SF20-related disorder | Benign (Jan 21, 2024) | ||
2-227363751-G-A | Likely benign (Jan 26, 2024) | |||
2-227363753-C-T | not specified | Uncertain significance (May 17, 2023) | ||
2-227363760-C-A | Benign (Dec 11, 2023) | |||
2-227363775-A-G | Likely benign (Jun 23, 2023) | |||
2-227363778-G-A | TM4SF20-related disorder | Benign (Dec 07, 2023) | ||
2-227363807-C-A | Uncertain significance (Jul 10, 2023) | |||
2-227363807-CCTCCAGAAT-C | Uncertain significance (May 16, 2021) | |||
2-227363819-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
2-227363825-G-A | TM4SF20-related disorder | Uncertain significance (May 26, 2023) | ||
2-227363842-A-G | Benign (Dec 07, 2023) | |||
2-227363855-T-C | Specific language impairment 5 | Likely benign (Apr 23, 2021) | ||
2-227363868-G-C | not specified | Uncertain significance (Dec 17, 2023) | ||
2-227363883-G-T | Uncertain significance (Dec 02, 2021) | |||
2-227363902-C-T | Uncertain significance (Jan 22, 2024) | |||
2-227363904-C-T | Specific language impairment 5 | Uncertain significance (May 10, 2023) | ||
2-227363928-A-G | Likely benign (Jul 06, 2022) | |||
2-227363957-G-A | TM4SF20-related disorder | Uncertain significance (Dec 09, 2022) | ||
2-227363997-T-A | Uncertain significance (Jul 21, 2021) | |||
2-227364014-T-C | Uncertain significance (Jul 23, 2023) | |||
2-227366083-A-G | Likely benign (Jul 29, 2023) | |||
2-227366120-T-C | Benign (Jan 29, 2024) | |||
2-227366135-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
2-227366145-T-A | Uncertain significance (Aug 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TM4SF20 | protein_coding | protein_coding | ENST00000304568 | 4 | 19840 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000186 | 0.486 | 125719 | 0 | 28 | 125747 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.396 | 131 | 119 | 1.10 | 0.00000550 | 1501 |
Missense in Polyphen | 49 | 46.227 | 1.06 | 572 | ||
Synonymous | 0.306 | 43 | 45.6 | 0.942 | 0.00000244 | 449 |
Loss of Function | 0.340 | 6 | 6.97 | 0.861 | 2.94e-7 | 90 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.000307 | 0.000298 |
East Asian | 0.0000552 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000176 | 0.000176 |
Middle Eastern | 0.0000552 | 0.0000544 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Polytopic transmembrane protein that inhibits regulated intramembrane proteolysis (RIP) of CREB3L1, inhibiting its activation and the induction of collagen synthesis (PubMed:25310401, PubMed:27499293). In response to ceramide, which alters TM4SF20 membrane topology, stimulates RIP activation of CREB3L1 (PubMed:27499293). Ceramide reverses the direction through which transmembrane helices are translocated into the endoplasmic reticulum membrane during translation of TM4SF20, this mechanism is called 'regulated alternative translocation' (RAT) and regulates the function of the transmembrane protein (PubMed:27499293). {ECO:0000269|PubMed:25310401, ECO:0000269|PubMed:27499293}.;
- Disease
- DISEASE: Specific language impairment 5 (SLI5) [MIM:615432]: A disorder characterized by a delay in early speech acquisition. It is usually associated with cerebral white matter abnormalities on brain MRI. Some individuals may show disorders in communication, consistent with autism spectrum disorder, or global developmental delay, although others ultimately show normal cognitive function. Penetrance is incomplete and expressivity is variable. {ECO:0000269|PubMed:23810381}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0835
Intolerance Scores
- loftool
- 0.824
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.53
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tm4sf20
- Phenotype
Gene ontology
- Biological process
- negative regulation of proteolysis
- Cellular component
- endoplasmic reticulum membrane;plasma membrane;focal adhesion;integral component of membrane
- Molecular function